ArticleThe pharmacogenomics journal2019
Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?
A Calcagno et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it